logo
logo

Latest Financial Updates

Read latest financial news update from our blog

Macy's Inc. Q2 2024 Earnings: EPS of $0.53 Beats Estimates, Revenue of $4.9 Billion Misses Expectations
Macy's Inc. Q2 2024 Earnings: EPS of $0.53 Beats Estimates, Revenue of $4.9 Billion Misses Expectations

On August 21, 2024, Macy's Inc (M, Financial) released its 8-K filing reporting financial...

Admin | Finance | 12 weeks ago

read more
Macy's Inc. Q2 2024 Earnings: EPS of $0.53 Beats Estimates, Revenue of $4.9 Billion Misses Expectations
Macy's Inc. Q2 2024 Earnings: EPS of $0.53 Beats Estimates, Revenue of $4.9 Billion Misses Expectations

On August 21, 2024, Macy's Inc (M, Financial) released its 8-K filing reporting financial...

Admin | Finance | 12 weeks ago

read more
KBW Ventures debuts in Egypt by investing in NoorNation
KBW Ventures debuts in Egypt by investing in NoorNation

Egypt-based climatetech NoorNation has received an undisclosed investment from KBW Venture...

Admin | Finance | 12 weeks ago

read more
Analog Devices Inc. (ADI) Q3 2024 Earnings: Revenue Surpasses Estimates at $2.31 Billion, GAAP EPS at $0.79
Analog Devices Inc. (ADI) Q3 2024 Earnings: Revenue Surpasses Estimates at $2.31 Billion, GAAP EPS at $0.79

On August 21, 2024, Analog Devices Inc (ADI, Financial) released its 8-K filing for the fi...

Admin | Finance | 12 weeks ago

read more
Woodward upgraded at Truist on higher aircraft output (NASDAQ:WWD)
Woodward upgraded at Truist on higher aircraft output (NASDAQ:WWD)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your...

Admin | Finance | 12 weeks ago

read more
Kamala Harris' grocery price gouging ban will get left on the shelf, strategist says
Kamala Harris' grocery price gouging ban will get left on the shelf, strategist says

Jeff Weniger, Head of Equity Strategy at WisdomTree, spoke with Quartz for the latest inst...

Admin | Finance | 12 weeks ago

read more
Alpha Tau Medical stock holds Buy rating on clinical trial updates By Investing.com
Alpha Tau Medical stock holds Buy rating on clinical trial updates By Investing.com

On Wednesday, H.C. Wainwright maintained its Buy rating and a $9.00 price target on shares...

Admin | Finance | 12 weeks ago

read more
Metagenomi shares target cut by +40% on Pfizer gene therapy results By Investing.com
Metagenomi shares target cut by +40% on Pfizer gene therapy results By Investing.com

On Wednesday, H.C. Wainwright adjusted its outlook on Metagenomi Inc (NASDAQ:MGX), lowerin...

Admin | Finance | 12 weeks ago

read more

Join Our Newsletter

join our newsletter to receive update from us